<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="study:id" content="epcor-rminichop-maic-1ldlbcl-darrah-ps1942">
    <meta name="study:title" content="PS1942 - Epcor + R-miniCHOP vs R-miniCHOP in 1L DLBCL (MAIC)">
    <meta name="study:fileName" content="Abstracts/EPCOR-RMINICHOP-MAIC-1LDLBCL-DARRAH-PS1942.html">
    <meta name="study:cancerTypes" content="DLBCL,LBCL,B-NHL">
    <meta name="study:lineOfTherapy" content="1L">
    <meta name="study:evidenceType" content="Clinical trial">
    <meta name="study:drugs" content="Epcoritamab,Bispecific antibodies,Rituximab,Monoclonal Antibody,Cyclophosphamide,Doxorubicin,Vincristine,Prednisone,Chemotherapy,CIT">

    <title>PS1942: Epcor + R-miniCHOP vs R-miniCHOP in 1L DLBCL (MAIC) (Darrah) - SOBI Themed</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <script src="https://d3js.org/d3.v7.min.js"></script>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="abstract_styles.css">
</head>
<body class="abstract-page-body">
    <div class="slide-container">
        <div class="visual-abstract-container">
            <h2 class="visual-abstract-title">Visual Summary: PS1942 - Epcor + R-miniCHOP vs R-miniCHOP in 1L DLBCL (MAIC)</h2>
            <div class="visual-abstract-grid">
                <div class="visual-abstract-item">
                    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="var(--sobi-teal)"> <path d="M12 6.096c-1.058 0-2.02.468-2.704 1.248-.685.78-.996 1.788-.996 2.856s.311 2.076.996 2.856C9.98 13.84 10.942 14.31 12 14.31s2.02-.468 2.704-1.248.996-1.788.996 2.856-.311-2.076-.996-2.856C14.02 6.564 13.058 6.096 12 6.096zM12 12.81c-.53 0-1.008-.222-1.352-.588-.344-.366-.528-.852-.528-1.422s.184-1.056.528-1.422C10.992 9.012 11.47 8.79 12 8.79s1.008.222 1.352.588.528.852.528 1.422-.184-1.056-.528 1.422C13.008 12.588 12.53 12.81 12 12.81zm6.708 3.672A7.47 7.47 0 0012.024 15c-1.404 0-2.706.39-3.816 1.056A4.476 4.476 0 004.5 19.686V21h15v-1.314a4.476 4.476 0 00-3.792-3.624zM6.024 16.56c.84-.468 1.848-.768 2.904-.924A5.928 5.928 0 0112.024 15a5.928 5.928 0 013.096.636c1.056.156 2.064.456 2.904.924A2.988 2.988 0 0019.5 18.018V19.5h-15v-1.482a2.988 2.988 0 001.524-2.458zM4.5 7.032c0-1.068.312-2.076.996-2.856S7.2 3 8.256 3A7.47 7.47 0 0112.024 1.5c1.404 0 2.706.39 3.816 1.056A4.476 4.476 0 0119.5 6.186V7.5H4.5v-.468zM18 4.56c-.84.468-1.848-.768-2.904-.924A5.928 5.928 0 0012.024 6a5.928 5.928 0 00-3.096.636 7.524 7.524 0 00-2.904.924A2.988 2.988 0 014.5 7.482V6H3V4.5A1.5 1.5 0 014.5 3h15A1.5 1.5 0 0121 4.5V6h-1.5v1.482a2.988 2.988 0 01-1.524 2.458L18 4.56z" />
                    </svg>
                    <h4>Population & Aim</h4>
                    <p>1L DLBCL pts, elderly/frail (EPCORE NHL-2 N=28, COTA N=46). Aim: Compare Epcor+R-miniCHOP vs R-miniCHOP (MAIC).</p>
                </div>
                <div class="visual-abstract-item">
                    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="var(--sobi-teal)"> <path fill-rule="evenodd" d="M12 2.25c-2.362 0-4.474.924-6.04 2.446a.75.75 0 001.06 1.06A7.501 7.501 0 0112 3.75c2.362 0 4.474.924 6.04 2.446a.75.75 0 101.06-1.06A8.963 8.963 0 0012 2.25zM3.696 7.54a.75.75 0 00-1.06 1.06A8.963 8.963 0 0012 21.75a8.963 8.963 0 009.364-13.15.75.75 0 10-1.06-1.06A7.501 7.501 0 0112 20.25a7.501 7.501 0 01-8.304-12.71zm5.158 7.814a.75.75 0 00-1.061-1.06L6 16.108V13.5a.75.75 0 00-1.5 0v4.5a.75.75 0 00.75.75h4.5a.75.75 0 000-1.5H7.892l1.962-1.963zm6.392-3.188a.75.75 0 00-1.06 1.061L16.108 15H13.5a.75.75 0 000 1.5h4.5a.75.75 0 00.75-.75v-4.5a.75.75 0 00-1.5 0v2.108l-1.962-1.962z" clip-rule="evenodd" />
                    </svg>
                    <h4>Methodology</h4>
                    <p>Epcor + R-miniCHOP vs R-miniCHOP. Match-adjusted indirect comparison (MAIC) via IPTW.</p>
                </div>
                <div class="visual-abstract-item">
                     <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="var(--sobi-orange)"> <path d="M3 13.5a.75.75 0 01.75-.75h16.5a.75.75 0 010 1.5H3.75A.75.75 0 013 13.5zM3 8.25a.75.75 0 01.75-.75h16.5a.75.75 0 010 1.5H3.75A.75.75 0 013 8.25zM3 18.75a.75.75 0 01.75-.75h16.5a.75.75 0 010 1.5H3.75A.75.75 0 013 18.75zM20.25 3a.75.75 0 00-.75.75v16.5a.75.75 0 001.5 0V3.75a.75.75 0 00-.75-.75z" />
                        <path fill-rule="evenodd" d="M9.97 4.28a.75.75 0 01.75-.75H12a.75.75 0 01.75.75v10.174l3.108-3.293a.75.75 0 111.084 1.038l-4.5 4.75a.75.75 0 01-1.084 0l-4.5-4.75a.75.75 0 111.084-1.038L9.97 14.454V4.28z" clip-rule="evenodd" />
                    </svg>
                    <h4>Key Efficacy (Epcor+R-miniCHOP vs R-miniCHOP)</h4>
                    <p>CR Rate: <span class="highlight-value">92.8% vs 67.0%</span> (OR 1.38, P=0.003). OS HR: <span class="highlight-value">0.20</span> (P=0.042).</p>
                </div>
                <div class="visual-abstract-item">
                    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="var(--sobi-orange)"> <path fill-rule="evenodd" d="M12 2.25c-5.385 0-9.75 4.365-9.75 9.75s4.365 9.75 9.75 9.75 9.75-4.365 9.75-9.75S17.385 2.25 12 2.25zm-.092 14.444a.75.75 0 01-.092 0l-3.75-3.75a.75.75 0 111.06-1.06L12 14.813l3.182-3.182a.75.75 0 111.06 1.06l-3.75 3.75a.75.75 0 01-.53.22z" clip-rule="evenodd" />
                    </svg>
                    <h4>Conclusion</h4>
                    <p>Epcor + R-miniCHOP significantly improves CR & survival vs R-miniCHOP alone in this population.</p>
                </div>
            </div>
        </div>

        <div class="text-center mb-8">
            <h1 class="abstract-header-title">PS1942 - Match-adjusted comparative analysis of the efficacy of Epcoritamab + R-miniCHOP vs R-miniCHOP in previously untreated diffuse large B-cell lymphoma</h1>
            <p class="abstract-sub-header">Justin Darrah, Juraj Duras, Tongsheng Wang, Guihua Zhang, Alex Mutebi, Vardhaman Patel, Anthony Wang, Mohammad Atiya, Malene Risum</p>
            <p class="abstract-meta-info mt-2">EHA2025 Congress | Abstract #PS1942 | Poster Presentation | Session: Aggressive Non-Hodgkin lymphoma - Clinical</p>
        </div>

        <div class="grid md:grid-cols-2 gap-x-8 gap-y-6">
            <div>
                <div class="abstract-card">
                    <h2 class="abstract-section-title">Background</h2>
                    <ul class="list-disc list-inside text-sm space-y-1 pl-2">
                        <li>Epcoritamab (epcor) is a subcutaneously administered CD3xCD20 bispecific antibody.</li>
                        <li>EPCORE NHL-2 (Arm 8) showed high response rates and compelling survival with epcor + R-miniCHOP in 1L DLBCL patients (pts) unable to tolerate standard R-CHOP.</li>
                    </ul>
                </div>

                <div class="abstract-card">
                    <h2 class="abstract-section-title">Aims</h2>
                    <p class="text-sm mb-1">To conduct a match-adjusted comparative analysis of efficacy outcomes in pts with 1L DLBCL treated with epcor + R-miniCHOP (EPCORE NHL-2) vs R-miniCHOP alone (COTA database), in the absence of head-to-head data.</p>
                </div>

                <div class="abstract-card">
                    <h2 class="abstract-section-title">Methods & Study Design</h2>
                    <ul class="list-disc list-inside text-sm space-y-1 mb-3 pl-2">
                        <li>Data Sources:
                            <ul class="list-circle list-inside ml-4">
                                <li>Epcor + R-miniCHOP: Individual patient data (IPD) from Arm 8 of EPCORE NHL-2 (N=28; data cutoff: May 2024; MFU: 16.8 mo).</li>
                                <li>R-miniCHOP alone: IPD from COTA US electronic health records database (N=46; Jan 2019 - Mar 2024; MFU: 19.4 mo).</li>
                            </ul>
                        </li>
                        <li>Statistical Method: Inverse Probability of Treatment Weighting (IPTW) to balance cohorts on key baseline characteristics (age, gender, ECOG PS, COO, LDH, Ann Arbor Stage, double/triple-hit, WBC).</li>
                        <li>Outcomes Compared: ORR, CR rate, PFS, OS.</li>
                        <li>Analysis Models: Weighted logistic regression (ORs for response) and Cox proportional-hazards models (HRs for time-to-event).</li>
                    </ul>
                    <div class="study-design-schema">
                        <h3 class="schema-title">MAIC Design: Epcor+R-miniCHOP vs R-miniCHOP in 1L DLBCL</h3>
                        <div class="schema-enrollment">
                            <strong>Patient Data Sources</strong>
                        </div>
                        <div class="schema-arrow-down">▼</div>
                        <div class="schema-phase-group justify-around">
                            <div class="schema-phase cohort-a" style="flex-basis: 48%;">
                                <strong>EPCORE NHL-2 (Arm 8)</strong>
                                <span>Epcor + R-miniCHOP (N=28 IPD)</span>
                                <span>(ESS after matching = 23)</span>
                            </div>
                             <div class="schema-phase cohort-b" style="flex-basis: 48%;">
                                <strong>COTA Database (RWD)</strong>
                                <span>R-miniCHOP alone (N=46 IPD)</span>
                                <span>(ESS after matching = 41)</span>
                            </div>
                        </div>
                        <div class="schema-arrow-down">▼</div>
                        <div class="schema-phase-group">
                             <div class="schema-phase" style="flex-basis: 100%; background-color: var(--sobi-light-gray-bg); border-color: var(--sobi-dark-blue);">
                                <strong>Match-Adjusted Indirect Comparison (MAIC)</strong>
                                <span>Using Inverse Probability of Treatment Weighting (IPTW)</span>
                            </div>
                        </div>
                        <div class="schema-arrow-down">▼</div>
                        <div class="schema-assessment-points">
                           <span>Compare ORR, CR (Adjusted OR)</span>
                           <span>Compare PFS, OS (Adjusted HR)</span>
                        </div>
                    </div>
                </div>
            </div>

            <div>
                <div class="abstract-card">
                    <h2 class="abstract-section-title">Patient Characteristics (Pre-Adjustment)</h2>
                    <p class="text-sm mb-2">Epcor + R-miniCHOP pts (N=28) were older (≥75 years: 96.4% vs 69.6%), had higher LDH (64.3% vs 45.7%), more Stage III/IV (64.3% vs 47.8%), and higher WBC (21.4% vs 6.5%) vs R-miniCHOP pts (N=46). Cohorts balanced after MAIC.</p>
                </div>
                
                <div class="abstract-card">
                    <h2 class="abstract-section-title">Efficacy Results (Match-Adjusted Comparison)</h2>
                    <p class="text-sm mb-1">Effective Sample Size (ESS): Epcor + R-miniCHOP (N=23), R-miniCHOP (N=41).</p>
                    <div class="table-container">
                        <table>
                            <thead>
                                <tr><th>Outcome</th><th>Epcor + R-miniCHOP (ESS=23)</th><th>R-miniCHOP (ESS=41)</th><th>OR/HR (95% CI)</th><th>P-value</th></tr>
                            </thead>
                            <tbody>
                                <tr><td>ORR</td><td>100.0%</td><td>91.9%</td><td>1.07 (0.99-1.16)</td><td>0.08</td></tr>
                                <tr><td>CR Rate</td><td>92.8%</td><td>67.0%</td><td>1.38 (1.10-1.75)</td><td class="highlight">0.003</td></tr>
                                <tr><td>PFS</td><td colspan="2">HR for Epcor+R-miniCHOP vs R-miniCHOP</td><td>0.36 (0.12-1.10)</td><td>0.054</td></tr>
                                <tr><td>OS</td><td colspan="2">HR for Epcor+R-miniCHOP vs R-miniCHOP</td><td>0.20 (0.04-0.89)</td><td class="highlight">0.042</td></tr>
                            </tbody>
                        </table>
                    </div>
                    <div class="chart-container my-4">
                        <svg id="epcorRminiCHOPResponseChart" width="400" height="300"></svg>
                        <div id="epcorRminiCHOPResponseLegend" class="legend"></div>
                    </div>
                </div>
                <div class="abstract-card">
                     <h2 class="abstract-section-title">Safety</h2>
                     <p class="text-sm">Safety data for the individual arms (EPCORE NHL-2 and COTA) were not detailed in this MAIC-focused abstract. The abstract states EPCORE NHL-2 Arm 8 demonstrated a manageable safety profile in its primary publication.</p>
                </div>
            </div>
        </div>

        <div class="abstract-card mt-6">
            <h2 class="abstract-section-title">Summary & Conclusion</h2>
            <ul class="list-disc list-inside text-sm space-y-1 pl-2">
                <li>This matched analysis suggests that combining epcoritamab with R-miniCHOP significantly increases the CR rate (by 38%) and reduces the risk of death by 80% compared with R-miniCHOP alone.</li>
                <li>A 64% reduction in the risk of progression was also observed, trending towards statistical significance.</li>
                <li>These benefits are observed despite small sample sizes and limited follow-up.</li>
            </ul>
        </div>

        <div class="abstract-card mt-6 abbreviations-list">
            <h2 class="abstract-section-title">Abbreviations</h2>
            <p>1L, First-Line; Ab, Antibody; CI, Confidence Interval; CIT, Chemoimmunotherapy; COO, Cell of Origin; COTA, Cancer Outcomes Tracking and Analysis database; CR, Complete Response; DLBCL, Diffuse Large B-Cell Lymphoma; ECOG PS, Eastern Cooperative Oncology Group Performance Status; Epcor, Epcoritamab; ESS, Effective Sample Size; GCB, Germinal Center B-cell like; HR, Hazard Ratio; IPD, Individual Patient Data; IPTW, Inverse Probability of Treatment Weighting; LDH, Lactate Dehydrogenase; MAIC, Match-Adjusted Indirect Comparison; MFU, Median Follow-up; mo, Months; OR, Odds Ratio; ORR, Overall Response Rate; OS, Overall Survival; PFS, Progression-Free Survival; Pts, Patients; R-CHOP, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone; R-miniCHOP, Rituximab + reduced-intensity CHOP; WBC, White Blood Cell.</p>
        </div>

        <div class="abstract-card mt-6 reference-section">
            <h2 class="abstract-section-title">
                Reference
                <button id="copyReferenceBtn" class="copy-reference-button" title="Copy Reference">
                    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 20 20" fill="currentColor">
                        <path d="M7 3.5A1.5 1.5 0 018.5 2h3.879a1.5 1.5 0 011.06.44l3.122 3.121A1.5 1.5 0 0117 6.621V16.5a1.5 1.5 0 01-1.5 1.5h-7A1.5 1.5 0 017 16.5v-13z" />
                        <path d="M4.5 6A1.5 1.5 0 003 7.5v10A1.5 1.5 0 004.5 19h7a1.5 1.5 0 001.5-1.5v-2.5a.75.75 0 00-1.5 0v2.5a.5.5 0 01-.5.5h-7a.5.5 0 01-.5-.5v-10a.5.5 0 01.5-.5h2.5a.75.75 0 000-1.5H4.5z" />
                    </svg>
                    Copy
                </button>
            </h2>
            <p id="referenceSectionContent">Darrah J, Duras J, Wang T, et al. Match-adjusted comparative analysis of the efficacy of Epcoritamab + R-miniCHOP vs R-miniCHOP in previously untreated diffuse large B-cell lymphoma. Abstract #PS1942 presented at the European Hematology Association (EHA) Congress. June 12–15, 2025, Milan, Italy.</p>
        </div>

        <div class="abstract-footer-info">
            <p>EHA2025 Congress | Abstract #PS1942 | Abstract Release: 05/14/25 | Presentation: June 14, 2025</p>
            <p>For Research & Informational Purposes Only.</p>
        </div>
    </div>
    <script defer src="abstract_features.js"></script>
    <script>
    function drawEpcorRminiCHOPResponseChart(containerId, legendContainerId) {
        const chartTitle = "Response Rates (MAIC): Epcor+R-miniCHOP vs R-miniCHOP";
        const chartData = [
            { group: "Epcor + R-miniCHOP (ESS=23)", CR_Rate: 92.8, ORR: 100.0 },
            { group: "R-miniCHOP (ESS=41)", CR_Rate: 67.0, ORR: 91.9 }
        ];
        const subgroups = ["CR_Rate", "ORR"];
        const displayLabels = { "CR_Rate": "CR Rate (%)", "ORR": "ORR (%)" };
        const units = "%";

        const svg = d3.select(containerId);
        const legendContainer = d3.select(legendContainerId);
        svg.selectAll("*").remove();
        legendContainer.selectAll("*").remove();

        let containerWidth = 400;
        const chartWrapper = svg.node() ? svg.node().closest('.chart-container') : null;
        if (chartWrapper) {
            containerWidth = Math.max(chartWrapper.getBoundingClientRect().width * 0.95, 300);
        }
        
        const svgWidth = containerWidth;
        const svgHeight = +svg.attr("height");
        const margin = { top: 50, right: 20, bottom: 70, left: 60 };
        const chartWidth = svgWidth - margin.left - margin.right;
        const chartHeight = svgHeight - margin.top - margin.bottom;

        if (chartWidth <= 0 || chartHeight <=0) return;

        const g = svg.append("g").attr("transform", \`translate(\${margin.left},\${margin.top})\`);
        const groups = chartData.map(d => d.group);
        
        const xScaleGroups = d3.scaleBand().domain(groups).range([0, chartWidth]).padding(0.4);
        const xScaleSubgroups = d3.scaleBand().domain(subgroups).range([0, xScaleGroups.bandwidth()]).padding(0.1);
        const yScale = d3.scaleLinear().domain([0, 100]).range([chartHeight, 0]);

        const color = d3.scaleOrdinal().domain(subgroups).range(["var(--sobi-teal)", "var(--sobi-orange)"]);

        g.append("g").attr("transform", \`translate(0,\${chartHeight})\`).call(d3.axisBottom(xScaleGroups))
            .selectAll("text").attr("class", "axis-text").style("font-size", "9px").attr("transform", "rotate(-10) translate(-5,0)").style("text-anchor", "end");
        
        g.append("g").call(d3.axisLeft(yScale).ticks(5).tickFormat(d => d + "%"))
            .selectAll("text").attr("class", "axis-text").style("font-size", "10px");
        
        g.append("text").attr("transform", "rotate(-90)").attr("y", 0 - margin.left + 15).attr("x", 0 - (chartHeight / 2))
            .attr("dy", "1em").style("text-anchor", "middle").attr("class", "axis-label").text("Response Rate (%)");

        g.append("g").attr("class", "grid").call(d3.axisLeft(yScale).ticks(5).tickSize(-chartWidth).tickFormat(""))
            .selectAll("line").style("stroke", "var(--sobi-light-gray)").style("stroke-opacity", "0.7");

        const groupBars = g.selectAll(".group-bar").data(chartData).enter().append("g")
            .attr("class", "group-bar").attr("transform", d => \`translate(\${xScaleGroups(d.group)},0)\`);

        groupBars.selectAll("rect")
            .data(d => subgroups.map(key => ({ key: key, value: d[key] })))
            .enter().append("rect")
            .attr("x", d => xScaleSubgroups(d.key)).attr("y", d => yScale(d.value))
            .attr("width", xScaleSubgroups.bandwidth()).attr("height", d => chartHeight - yScale(d.value))
            .attr("fill", d => color(d.key)).attr("rx", 2).attr("ry", 2);

        groupBars.selectAll(".bar-label")
            .data(d => subgroups.map(key => ({ key: key, value: d[key] })))
            .enter().append("text")
            .attr("class", "chart-label")
            .attr("x", d => xScaleSubgroups(d.key) + xScaleSubgroups.bandwidth() / 2)
            .attr("y", d => yScale(d.value) - 4).attr("text-anchor", "middle")
            .style("font-size", "9px").style("fill", "var(--sobi-dark-text)")
            .text(d => \`\${d.value.toFixed(1)}\${units}\`);
        
        svg.append("text").attr("x", svgWidth / 2).attr("y", margin.top / 2)
            .attr("text-anchor", "middle").style("font-size", "13px").style("font-weight", "600")
            .style("fill", "var(--sobi-dark-blue)").text(chartTitle);

        // Adding P-values below the chart
        const pValueTexts = [
            {label: "CR Rate (vs R-miniCHOP)", p: 0.003, color: "var(--sobi-orange)"},
            {label: "ORR (vs R-miniCHOP)", p: 0.08, color: "var(--sobi-dark-text)"}
        ];
        pValueTexts.forEach((item, i) => {
            g.append("text")
             .attr("x", chartWidth / 2)
             .attr("y", chartHeight + 35 + (i * 12)) // Position below x-axis
             .attr("text-anchor", "middle")
             .attr("class", "axis-text")
             .style("font-size", "9px")
             .style("font-weight", item.p < 0.05 ? "bold" : "normal")
             .style("fill", item.color)
             .text(\`\${item.label}: P=\${item.p.toFixed(3)}\`);
        });


        const legendData = subgroups.map(key => ({ label: displayLabels[key], color: color(key) }));
        const legendItems = legendContainer.selectAll(".legend-item").data(legendData).enter().append("div").attr("class", "legend-item");
        legendItems.append("div").attr("class", "legend-color-box").style("background-color", d => d.color);
        legendItems.append("span").text(d => d.label);
    }
    
    function debounce(func, wait) {
        let timeout;
        return function executedFunction(...args) {
            const later = () => { clearTimeout(timeout); func(...args); };
            clearTimeout(timeout);
            timeout = setTimeout(later, wait);
        };
    };

    const debouncedDrawEpcorRminiCHOPChart = debounce(() => drawEpcorRminiCHOPResponseChart("#epcorRminiCHOPResponseChart", "#epcorRminiCHOPResponseLegend"), 250);
    
    window.addEventListener('resize', debouncedDrawEpcorRminiCHOPChart);
    document.addEventListener('DOMContentLoaded', debouncedDrawEpcorRminiCHOPChart);
    if (document.readyState === "complete" || document.readyState === "interactive") {
         setTimeout(debouncedDrawEpcorRminiCHOPChart, 0); 
    }
    </script>
</body>
</html>